Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Cobo

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Statistics in Medicine|August 31, 2017
Two-stage designs versus European scaled average designs in bioequivalence studies for highly variable drugs: Which to choose?Eduard Molins, Erik Cobo, Jordi Ocaña
BMJ Open|November 15, 2017
National citation patterns of <i>NEJM</i>, <i>The Lancet</i>, <i>JAMA</i> and <i>The BMJ</i> in the lay press: a quantitative content analysisGonzalo Casino, Roser Rius, Erik Cobo
Gaceta Sanitaria|April 19, 2008
[The STROBE statement or how to improve the reporting of observational studies]Esteve Fernández, Erik Cobo, Pilar Guallar-Castillón
Trials|January 31, 2018
Are CONSORT checklists submitted by authors adequately reflecting what information is actually reported in published papers?David Blanco, Alice M Biggane, Erik Cobo, et al.
Statistics in Medicine|December 8, 2004
Efficiency of the cross-over design: an empirical estimationRaquel Garcia, Marta Benet, Catalina Arnau, et al.
Pharmaceutical Statistics|July 22, 2008
Evaluation of a sequential global test of improved recovery following stroke as applied to the ICTUS trial of citicolineKim Bolland, John Whitehead, Erik Cobo, et al.
Cirugia Espanola|June 13, 2022
Description of survival with numerical and graphic indicators. Basics and mistakes to avoidGuadalupe Gómez Melis, Jordi Cortés Martínez, Erik Cobo Valeri
Biometrical Journal. Biometrische Zeitschrift|October 1, 2020
An iterative method to protect the type I error rate in bioequivalence studies under two-stage adaptive 2×2 crossover designsEduard Molins, Detlew Labes, Helmut Schütz, et al.
Journal of Clinical Epidemiology|July 27, 2014
A hazard ratio was estimated by a ratio of median survival times, but with considerable uncertaintyJordi Cortés, José A González, Michael J Campbell, et al.
F1000Research|December 12, 2019
A survey exploring biomedical editors' perceptions of editorial interventions to improve adherence to reporting guidelinesDavid Blanco, Darko Hren, Jamie J Kirkham, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Statistics in Medicine|August 31, 2017
Two-stage designs versus European scaled average designs in bioequivalence studies for highly variable drugs: Which to choose?Eduard Molins, Erik Cobo, Jordi Ocaña
BMJ Open|November 15, 2017
National citation patterns of <i>NEJM</i>, <i>The Lancet</i>, <i>JAMA</i> and <i>The BMJ</i> in the lay press: a quantitative content analysisGonzalo Casino, Roser Rius, Erik Cobo
Gaceta Sanitaria|April 19, 2008
[The STROBE statement or how to improve the reporting of observational studies]Esteve Fernández, Erik Cobo, Pilar Guallar-Castillón
Trials|January 31, 2018
Are CONSORT checklists submitted by authors adequately reflecting what information is actually reported in published papers?David Blanco, Alice M Biggane, Erik Cobo, et al.
Statistics in Medicine|December 8, 2004
Efficiency of the cross-over design: an empirical estimationRaquel Garcia, Marta Benet, Catalina Arnau, et al.
Pharmaceutical Statistics|July 22, 2008
Evaluation of a sequential global test of improved recovery following stroke as applied to the ICTUS trial of citicolineKim Bolland, John Whitehead, Erik Cobo, et al.
Cirugia Espanola|June 13, 2022
Description of survival with numerical and graphic indicators. Basics and mistakes to avoidGuadalupe Gómez Melis, Jordi Cortés Martínez, Erik Cobo Valeri
Biometrical Journal. Biometrische Zeitschrift|October 1, 2020
An iterative method to protect the type I error rate in bioequivalence studies under two-stage adaptive 2×2 crossover designsEduard Molins, Detlew Labes, Helmut Schütz, et al.
Journal of Clinical Epidemiology|July 27, 2014
A hazard ratio was estimated by a ratio of median survival times, but with considerable uncertaintyJordi Cortés, José A González, Michael J Campbell, et al.
F1000Research|December 12, 2019
A survey exploring biomedical editors' perceptions of editorial interventions to improve adherence to reporting guidelinesDavid Blanco, Darko Hren, Jamie J Kirkham, et al.
Pageof 7